Reclusive trader scores 20 years of winning trades. Learn how.
He had 20 straight years of winning trades without a single losing year… He had 20 straight years of winning trades without a single losing year…

And now, he is coming forward to share a brand-new forecast.
Click here to watch the video now.
Alexander A. Seelenberger net worth and biography

Alexander Seelenberger Biography and Net Worth

Alexander Seelenberger, MBA is the Chief Financial Officer of Vincerx. Mr Seelenberger has been a managing partner at Aurus Capital, a leading Latin American venture capital firm, heading its healthcare venture capital practice, since March 2009. In that role, Mr Seelenberger has co-founded and has been an executive director in several healthcare companies. From August 2007 to January 2009, Mr Seelenberger served as an associate at Athelera LLC, a New York-based boutique investment bank offering financial advisory services to clients in the United States, Latin America and Europe. Mr Seelenberger has served as a member of the board of directors of Andes Biotechnologies, a nucleic acid-based drug discovery and development company, since September 2009, Trigemina Holdings, Inc., a pharmaceutical company, since March 2012, Levita Magnetics, a magnetic surgical platform development company, since January 2012, Echopixel, Inc., a medical imaging device development company, since September 2012, and Algenis, a bioactive molecule development company, since December 2012. 

Mr Seelenberger received a BBA in business from the University of Chile and an MBA with high distinction from Harvard Business School, where he graduated as a Baker Scholar.

How old is Alexander A. Seelenberger?

Mr. Seelenberger is currently 43 years old. There are 3 older executives and no younger executives at Vincerx Pharma. The oldest executive at Vincerx Pharma is Mr. Tom C. Thomas J.D., Founder, Gen. Counsel & Chief Legal Officer, who is 63 years old. Learn More on Alexander A. Seelenberger's age.

What is Alexander A. Seelenberger's salary?

As the CFO of Vincerx Pharma, Inc., Mr. Seelenberger earned a total compensation package of $2,418,357.00 in 2020. Mr. Seelenberger earned a salary of $9,244.00, options awards of $2,386,160.00, and other compensation of $22,953.00. Learn More on Alexander A. Seelenberger's salary.

How do I contact Alexander A. Seelenberger?

The corporate mailing address for Mr. Seelenberger and other Vincerx Pharma executives is 260 SHERIDAN AVENUE SUITE 400, PALO ALTO CA, 94306. Vincerx Pharma can also be reached via phone at 650-800-6676. Learn More on Alexander A. Seelenberger's contact information.

Has Alexander A. Seelenberger been buying or selling shares of Vincerx Pharma?

Alexander A. Seelenberger has not been actively trading shares of Vincerx Pharma during the past quarter. Most recently, on Wednesday, December 22nd, Alexander A. Seelenberger bought 2,417 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $10.34 per share, with a total value of $24,991.78. Learn More on Alexander A. Seelenberger's trading history.

Who are Vincerx Pharma's active insiders?

Vincerx Pharma's insider roster includes Laura Bushnell (Director), Ahmed Hamdy (CEO), Raquel Izumi (Insider), Andrew McDonald (Director), Alexander Seelenberger (CFO), and Tom Thomas (Insider). Learn More on Vincerx Pharma's active insiders.

Are insiders buying or selling shares of Vincerx Pharma?

During the last year, Vincerx Pharma insiders bought shares 8 times. They purchased a total of 109,869 shares worth more than $274,555.74. The most recent insider tranaction occured on August, 24th when Director Christopher P Lowe bought 18,400 shares worth more than $30,360.00. Insiders at Vincerx Pharma own 23.6 % of the company. Learn More about insider trades at Vincerx Pharma.

Information on this page was last updated on 8/24/2022.

Alexander A. Seelenberger Insider Trading History at Vincerx Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2021Buy2,417$10.34$24,991.78View SEC Filing Icon  
See Full Table

Alexander A. Seelenberger Buying and Selling Activity at Vincerx Pharma

This chart shows Alexander A Seelenberger's buying and selling at Vincerx Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vincerx Pharma Company Overview

Vincerx Pharma logo
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $1.38
Low: $1.08
High: $1.40

50 Day Range

MA: $1.43
Low: $1.03
High: $1.72

2 Week Range

Now: $1.38
Low: $1.00
High: $17.49


137,762 shs

Average Volume

130,895 shs

Market Capitalization

$29.24 million

P/E Ratio


Dividend Yield



A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.